APTN · Adaptin Bio, Inc. · Investor Relations
$6.27
At close · Aug 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company's operating plan against its existing cash and determined that substantial doubt exists about the Company's ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.89M
Shares
9.23M
Volume · Aug 19
200
Avg daily vol (12 sessions)
256
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-01-22 | 2026 Sequire Investor Summit in Puerto Rico | Event |
Source: https://ir.adaptinbio.com/